Global Certificate in Drug Pricing and Market Access Strategies
-- ViewingNowThe Global Certificate in Drug Pricing and Market Access Strategies is a comprehensive course designed to meet the growing industry demand for experts who can navigate the complex landscape of pharmaceutical pricing and market access. This certificate program equips learners with essential skills to develop and implement effective pricing and market access strategies, ensuring patient access to life-saving treatments while maintaining financial sustainability for healthcare systems and pharmaceutical companies.
4,665+
Students enrolled
GBP £ 140
GBP £ 202
Save 44% with our special offer
ě´ ęłźě ě ëí´
100% ě¨ëźě¸
ě´ëěë íěľ
ęłľě ę°ëĽí ě¸ěŚě
LinkedIn íëĄíě ěśę°
ěëŁęšě§ 2ę°ě
죟 2-3ěę°
ě¸ě ë ěě
ë기 ę¸°ę° ěě
ęłźě ě¸ëśěŹí
⢠Introduction to Drug Pricing: Understanding the basics of drug pricing, including the factors that influence the cost of pharmaceutical products and the key stakeholders involved in the pricing process.
⢠Market Access Strategies: Exploring the various market access strategies that pharmaceutical companies use to ensure their products reach patients, including pricing strategies, reimbursement models, and value-based pricing.
⢠Health Economics and Outcomes Research: Examining the role of health economics and outcomes research in drug pricing and market access, including how these data are used to demonstrate the value of pharmaceutical products to payers.
⢠Payer Perspectives: Understanding the viewpoint of payers, including insurance companies, health plans, and government agencies, and how they make decisions about covering and reimbursing pharmaceutical products.
⢠Policy and Regulatory Environment: Examining the policy and regulatory environment for drug pricing and market access, including the role of government agencies, regulations, and policies that impact drug pricing.
⢠Global Drug Pricing Trends: Analyzing global drug pricing trends, including how drug pricing varies by country and the impact of these differences on market access and patient access to pharmaceutical products.
⢠Patient Access and Affordability: Exploring the issue of patient access and affordability, including the impact of high drug prices on patients and the strategies being used to improve access and affordability.
⢠Negotiation and Contracting: Understanding the process of negotiation and contracting between pharmaceutical companies and payers, including the key terms and conditions of these agreements and how they impact drug pricing and market access.
⢠Pricing and Reimbursement in Specific Markets: Examining the pricing and reimbursement systems in specific markets, including the United States, Europe, and emerging markets, and the challenges and opportunities in these markets.
⢠Market Access and Pricing in
ę˛˝ë Ľ 경ëĄ
ě í ěęą´
- 죟ě ě ëí 기본 ě´í´
- ěě´ ě¸ě´ ëĽěë
- ěť´í¨í° ë° ě¸í°ëˇ ě ꡟ
- 기본 ěť´í¨í° 기ě
- ęłźě ěëŁě ëí íě
ěŹě ęłľě ěę˛Šě´ íěíě§ ěěľëë¤. ě ꡟěąě ěí´ ě¤ęłë ęłźě .
ęłźě ěí
ě´ ęłźě ě ę˛˝ë Ľ ę°ë°ě ěí ě¤ěŠě ě¸ ě§ěęłź 기ě ě ě ęłľíŠëë¤. ꡸ę˛ě:
- ě¸ě ë°ě 기ę´ě ěí´ ě¸ěŚëě§ ěě
- ęśíě´ ěë 기ę´ě ěí´ ęˇě ëě§ ěě
- ęłľě ě겊ě ëł´ěě
ęłźě ě ěąęłľě ěźëĄ ěëŁí늴 ěëŁ ě¸ěŚě뼟 ë°ę˛ ëŠëë¤.
ě ěŹëë¤ě´ ę˛˝ë Ľě ěí´ ě°ëŚŹëĽź ě ííëę°
댏롰 ëĄëŠ ě¤...
ě죟 돝ë ě§ëʏ
ě˝ě¤ ěę°ëŁ
- 죟 3-4ěę°
- 쥰기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- 죟 2-3ěę°
- ě 기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- ě 체 ě˝ě¤ ě ꡟ
- ëě§í¸ ě¸ěŚě
- ě˝ě¤ ěëŁ
ęłźě ě ëł´ ë°ę¸°
íěŹëĄ ě§ëś
ě´ ęłźě ě ëšěŠě ě§ëśí기 ěí´ íěŹëĽź ěí ě˛ęľŹě뼟 ěě˛íě¸ě.
ě˛ęľŹěëĄ ę˛°ě ę˛˝ë Ľ ě¸ěŚě íë